Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis and Related Disorders|March 7, 2024
Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorderD Stastna, M Vachova, P Dusek, et al.
European Journal of Neurology|April 24, 2015
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1aT Uher, D Horakova, T Kalincik, et al.
European Journal of Clinical Investigation|July 20, 2007
Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemiaM Karpisek, D Stejskal, H Kotolova, et al.
Genes and Immunity|April 12, 2013
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndromeT Kalincik, C R G Guttmann, J Krasensky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2007
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control studyD Horakova, J L Cox, E Havrdova, et al.
AJNR. American Journal of Neuroradiology|June 27, 2015
Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated SyndromeM Varosanec, T Uher, D Horakova, et al.
European Journal of Neurology|November 23, 2016
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approachT Uher, M Vaneckova, M P Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2009
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosisE Havrdova, R Zivadinov, J Krasensky, et al.
Journal of Neurology|November 8, 2025
Big multiple sclerosis data network: novel modelling approaches for real-world data analysisM Trojano, P Iaffaldano, M Copetti, et al.
Multiple Sclerosis and Related Disorders|August 11, 2019
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuSD Horakova, P Rockova, J Jircikova, et al.
Pageof 3